TITLE

TIME RUNS OUT FOR AZT PROGRAM

AUTHOR(S)
Harding, Rick
PUB. DATE
October 1988
SOURCE
Advocate;10/25/88, Issue 510, p10
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports on the end of the United States federal program that provides free distribution of the AZT drug to AIDS patients. Implication of the program's closure on AIDS patients; Worth of the drug.
ACCESSION #
9873452

 

Related Articles

  • AIDS--Medicaid Coverage--Weaver v. Reagen.  // American Journal of Law & Medicine;1990, Vol. 16 Issue 3, p433 

    Reports on a United States Court of Appeals' decision regarding whether or not Missouri Medicaid can deny coverage of AZT treatment to AIDS patients. Limitation to those who meet diagnostic criteria; Result of the state's efforts to label AZT experimental; Presumption in favor of physician's...

  • US scientists may boycott AIDS congress. Cherry, Michael // Nature;12/10/1998, Vol. 396 Issue 6711, p504 

    Deals with the plan of some researchers to boycott the 2000 World AIDS Congress in Durban, in protest at the decision of South Africa's health minister to abandon planned programme to administer the antiviral agent AZT to HIV-positive pregnant women. Reason presented by South African for...

  • Alternating and Intermittent Regimens of Zidovudine and Dideoxycytidine in Patients with AIDS or AIDS-Related Complex. Skowron, Gail; Bozzete, Samuel A.; Lim, Lynette; Pettinelli, Carla B.; Schaumburg, Herbert H.; Arezzo, Joseph; Fisehl, Margaret A.; Powderly, William G.; Gocke, David J.; Richman, Douglas D.; Pottage, John C.; Antoniskis, Diana; McKinley, George F.; Hyslop, Newton E.; Ray, Graham; Simon, Gary; Reed, Nancy; LoFaro, Marsha L.; Uttamchandani, Raj B. // Annals of Internal Medicine;3/1/93, Vol. 118 Issue 5, p321 

    Discusses a study that aimed to determine whether alternating regimens of Zidovudine reduce the toxicity and maintain or increase the antiretroviral effect associated with the drug in patients with AIDS or AIDS-related complex. Adverse effects of the drug; Physical effects of the drugs on the...

  • Anemia and Erythropoiesis in Patients with the Acquired Immunodeficiency Syndrome (AIDS) and Kaposi Sarcoma Treated with Zidovudine. Walker, Robert E.; Parker, Robert I.; Kovacs, Joseph A.; Masur, Henry; Lane, H. Clifford; Carleton, Stephanie; Kirk, L. Edward; Gralnick, Harvey R.; Fauci, Anthony S. // Annals of Internal Medicine;Mar88, Vol. 108 Issue 3, p372 

    Evaluates the development of anemia as part of a trial of zidovudine therapy in AIDS patients with Kaposi sarcoma. Efficacy of zidovudine treatment; Mechanism of the anemia associated with zidovudine therapy; Bone marrow hispathology of patients with AIDS developing severe anemia on zidovudine...

  • Records Plan Draws Heat. Peterson, Robert W. // Advocate;12/5/89, Issue 539, p19 

    Reports on the impact of the attempt by the Oklahoma Department of Health (ODH) to gain access to the state's medicaid and AZT dispensation records on Oklahomans who have AIDS. Plan of ODH to develop a list of everyone in the state who has AIDS or who is asymptomatic but seropositive for...

  • Esophageal Ulceration Induced by Zidovudine. Edwards, Paul; Turner, Jennifer; Gold, Julian; Cooper, David A. // Annals of Internal Medicine;1/1/90, Vol. 112 Issue 1, p65 

    Reports the occurrence of nonspecific midesophageal ulceration in patients with AIDS who were taking zidovudine. Account of a related study; Possible causal link between ingestion of zidovudine capsules and esophageal ulceration; Implications for research.

  • PWA's head south for AZT. Popert, Ken // Body Politic;Nov86, Issue 132, p15 

    Reports on the migration of some Canadian persons with AIDS (PWA) to the U.S. to acquire azidothymidine (AZT), a drug that is proved to be effective against HIV. Findings of a U.S. study of AZT conducted by Burroughs Wellcome Co.; Criteria that had to be met by Canadian PWA in order to avail...

  • Antiretrovirals.  // Reactions Weekly;5/2/2009, Issue 1250, p9 

    The article describes the case of five patients with AIDS who acquired dermatological manifestation of immune reconstitution syndrome. The patients developed their respective conditions while undergoing antiretroviral therapy. Some of the drugs given to patients were efavirenz, prednisone,...

  • NEWSFRONT: NEW YORK.  // Advocate;12/22/87, Issue 488, p26 

    Reports that the New York State Health Department will use a multimillion-dollar fund to buy the drug AZT for low-income people with AIDS or AIDS-related complex (ARC).

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics